Low vs standard dose valganciclovir
Adverse events · solid organ transplant recipients
The review found no eligible studies for this question.
1 finding from 1 review
- Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients 2024 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found